PNC Financial Services Group’s Loncar China BioPharma ETF CHNA Stock Holding History

PNC Financial Services Group’s Portfolio CHNA Stock Details CHNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-652	Closed	-$15K	–	4168
2019 Q1	$15K	Hold	652	–	–	﹤0.01%	3482
2018 Q4	$13K	Buy	+652	New	+$13.5K	﹤0.01%	3466

Other funds holding CHNA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group's CHNA Position: Q2 2019 in Review

PNC Financial Services Group sold out of Loncar China BioPharma ETF (CHNA) in Q2 2019, closing a stake of 652 shares — an estimated $15K sold.

PNC Financial Services Group first reported a position in CHNA in Q4 2018 and held it in 2 quarters. The position peaked at $15K in Q1 2019. 2 funds tracked by Wall St. Rank hold CHNA as of Q2 2019.

PNC Financial Services Group reported no remaining Loncar China BioPharma ETF position as of Q2 2019 after selling out during the quarter.
PNC Financial Services Group sold 652 Loncar China BioPharma ETF shares in Q2 2019, an estimated $15K.
PNC Financial Services Group first reported a position in Loncar China BioPharma ETF in Q4 2018 and held it in 2 quarters.
PNC Financial Services Group's Loncar China BioPharma ETF position peaked at $15K in Q1 2019.
2 funds tracked by Wall St. Rank held Loncar China BioPharma ETF as of Q2 2019.

Based on PNC Financial Services Group's 13F filing for Q2 2019, filed 9 Aug 2019.